North America to lead global LNG liquefaction capacity increases
Published by Tom Mostyn,
GlobalData has reported that North America is expected to drive global LNG liquefaction capacity growth through planned and announced (new-build) projects between 2019 and 2023, contributing around 82% of the total growth.
The company’s report, ‘H2 2019 Global Capacity and Capital Expenditure Outlook for LNG Liquefaction Terminals – North American Companies Dominate Global Liquefaction Capacity Additions’, reveals that North America is expected to have a new-build LNG liquefaction capacity of 175.5 million tpy by 2023.
Planned projects with identifiable development plans account for most of the new-build capacity in the region with 51% or 89.2 million tpy, while early-stage announced projects account for the remaining capacity.
Dipayan Chakraborty, Oil and Gas Analyst at GlobalData, says: “In North America, 21 planned and announced projects are expected to start operations by 2023. Of these, the Rio Grande terminal in Texas has the highest LNG liquefaction capacity by 2023 with 17.6 million tpy.”
The Former Soviet Union is the second-highest region in terms of global LNG liquefaction capacity growth adding a new-build capacity of 18.7 million tpy by 2023. The Arctic-2 and Baltic terminals are the largest upcoming projects in the region with new-build capacities of 6.6 million tpy and 6.5 million tpy, respectively, by 2023.
Charaborty concludes: “Africa stands third globally with new-build LNG liquefaction capacity additions of 11.4 million tpy by 2023. The Coral Floating terminal in Mozambique is the largest upcoming liquefaction terminal in the region with a new-build capacity of 3.4 million tpy by 2023.”
Read the article online at: https://www.hydrocarbonengineering.com/gas-processing/26092019/north-america-to-lead-global-lng-liquefaction-capacity-increases/
You might also like
SP Chemicals selects Lummus' technologies
Lummus Technology has announced an integrated technology award from SP Chemicals and its subsidiary SP Olefins.